Showing results (2221-2230 of 2,380) with videos related to
Sort By:
Pageof 238
Plos One|July 7, 2011
Poly (A)+ transcriptome assessment of ERBB2-induced alterations in breast cell linesDirce Maria Carraro, Elisa Napolitano Ferreira, Gustavo de Campos Molina, et al.Oncotarget|October 6, 2017
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancerXiaoping Wang, Monica E Reyes, Dongwei Zhang, et al.Oncotarget|January 18, 2018
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapyJustin Greene, Anna Nguyen, Stacey M Bagby, et al.Biorxiv : the Preprint Server for Biology|April 10, 2026
eSIG-Net: Accurate prediction of single-mutation induced perturbations on protein interactions using a language modelXingxin Pan, Aditya Shrawat, Sidharth Raghavan, et al.Molecular & Cellular Proteomics : MCP|April 5, 2023
Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASPZeynep Cakir, Samuel J Lord, Yuan Zhou, et al.European Archives of Psychiatry and Clinical Neuroscience|November 14, 2018
Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosaHannah Pellkofer, Friedrich Ihler, Bernhard G Weiss, et al.Chest|August 18, 2024
Extracellular Vesicle-Encapsulated microRNAs and Respiratory Health Among American Indian Participants in the Strong Heart StudyChristina M Eckhardt, Haotian Wu, Gabriela Jackson, et al.Nature Methods|April 29, 2026
eSIG-Net: an interaction language model that decodes the protein code of single mutationsXingxin Pan, Aditya Shrawat, Sidharth Raghavan, et al.Science Advances|February 22, 2019
Source apportionment of circum-Arctic atmospheric black carbon from isotopes and modelingP Winiger, T E Barrett, R J Sheesley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancerM L Rothenberg, J R Eckardt, J G Kuhn, et al.Pageof 238